title: Detection of chromosomal imbalances in papillary bladder tumors by comparative genomic hybridization.
abstract: OBJECTIVE
  To identify those genetic alterations that are associated with bladder cancer invasion and progression.
  
  
  METHODS
  A total of 30 specimens of transitional cell carcinoma of the bladder were analyzed by comparative genomic hybridization. The results were compared and summarized with previously reported studies.
  
  
  RESULTS
  The most frequent chromosome changes detected in our series of tumors were losses in 9q, 9p, 8p, and 11p and gains in 8q, 1q, 20q, and 11q. Three regions of deletion on chromosome 9 were delineated, at 9p21-p22, 9q13-q22, and 9q31-q34. Gains in 1q and losses on 11p were significantly more frequent in pT1G2 tumors than in superficial (pTa) ones. In our study, the most striking differences were seen between pT1G3 and pT1G2 tumors. Gains on 10p and 6p and losses at 5q, 6q, and 18q were significantly more frequent in the former.
  
  
  CONCLUSIONS
  A summary of our results and those available from published reports suggest that several groups of chromosomal imbalances may be associated with specific steps along bladder cancer progression. These genetic changes assume two different patterns: those that are shared, but are more intensive in one stage than in the other, and those such as a gain on 3p that are unique to invasive tumors.
authors.affiliation: Departament de Biologia, Fisiologia i Immunologia, Universitat Autónoma de Barcelona, Barcelona, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Prat
authors.forename: M
authors.initials: M
authors.lastname: Bernués
authors.forename: M R
authors.initials: MR
authors.lastname: Caballín
authors.forename: J
authors.initials: J
authors.lastname: Egozcue
authors.forename: A
authors.initials: A
authors.lastname: Gelabert
authors.forename: R
authors.initials: R
authors.lastname: Miró
mesh_terms: D002291:Carcinoma, Papillary / Q000175:diagnosis / Q000235:genetics / Q000473:pathology; D002295:Carcinoma, Transitional Cell / Q000235:genetics* / Q000473:pathology; D002869:Chromosome Aberrations; D002872:Chromosome Deletion; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics; D002889:Chromosomes, Human, Pair 2 / Q000235:genetics; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics; D005260:Female; D006801:Humans; D019656:Loss of Heterozygosity / Q000235:genetics; D008297:Male; D009367:Neoplasm Staging; D009693:Nucleic Acid Hybridization / Q000379:methods*; D012150:Polymorphism, Restriction Fragment Length; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology